Dorman reported Q1 results affected by peak tariff costs due to FIFO accounting but expects margin normalization and growth by year-end. Management reaffirmed full-year guidance, projecting 7-9% sales growth and operating margins in the high teens by the end of 2024. A recent $450 million debt issuance doubled leverage to 2x net debt/EBITDA, increasing merger and acquisition risk but supporting ongoing share buybacks and free cash flow. Analysts see Dorman as undervalued with earnings power projected at $10 per share by 2027 and a price target of $160.
GNI Group has agreed to acquire 100% of Ayumi Pharmaceutical Holdings from shareholders led by Blackstone for about ¥44.8 billion. This acquisition significantly expands GNI's commercial footprint in Japan, especially in pain management and rheumatol...
Ripple's XRP Ledger is evolving from a simple payment network to a platform supporting tokenized real-world assets like securities, funds, repos, and loans. Ripple CTO Emeritus David Schwartz highlighted that this expansion allows enterprises to issu...
Public Storage's Q1 earnings were boosted by a foreign currency gain, masking underlying declines in revenue and occupancy, with full-year 2026 guidance showing flat to negative growth and a significant debt refinancing challenge amid high interest r...
Ascletis Pharma presented three key studies at the ADA 2026 Scientific Sessions highlighting its innovative oral treatments for obesity, including ASC39, ASC30, and ASC37. ASC39 showed potent, selective weight loss effects in animal models, ASC30 dem...
Akash Network (AKT) surged over 14% in 24 hours following a broader altcoin recovery driven by Bitcoin's 2.5% gain. AKT bounced from a previous resistance level turned support around $0.526 and rallied toward $0.96, with volume and development activi...
